AGRX - Agile Therapeutics -3.5% after Q2 earnings results are out August, 12 2020 10:51 AM Agile Therapeutics Inc. Agile Therapeutics (AGRX -3.5%) reports Q2 net loss was $10.8M or EPS loss of $0.12 vs. net loss of $3.5M, or EPS loss of $0.08 in Q2 2019.More news on: Agile Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...